Cargando…

Antagonizing Wnt Pathway in Diabetic Retinopathy

Detalles Bibliográficos
Autores principales:	Zhao, Ling, Patel, Sherrina H., Pei, Jacqueline, Zhang, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837055/ https://www.ncbi.nlm.nih.gov/pubmed/24264398 http://dx.doi.org/10.2337/db13-1309

Ejemplares similares

TCF7L2 Variation and Proliferative Diabetic Retinopathy
por: Luo, Jing, et al.
Publicado: (2013)

Clocking in on Diabetic Retinopathy
por: Kleinman, Mark E., et al.
Publicado: (2013)

Commentary: Burden of diabetic retinopathy
por: Bhattacharjee, Harsha, et al.
Publicado: (2021)

Novel strategy for screening of diabetic retinopathy
por: Takagi, Hitoshi
Publicado: (2017)

Commentary: Oral management of diabetic retinopathy
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Is there a place for inhibition of transforming growth factor‐β and the polyol pathway in therapy for diabetic retinopathy?
por: Hotta, Nigishi
Publicado: (2010)

Commentary: From diabetic retinopathy toward diabetic retinal disease
por: Saurabh, Kumar, et al.
Publicado: (2021)

Commentary: Diabetic retinopathy and its correlation with other diabetic complications
por: Delhiwala, Kushal, et al.
Publicado: (2021)

The Role of Glycemic Control and Variability in Diabetic Retinopathy
por: Chatziralli, Irini P.
Publicado: (2017)

Commentary: Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy
por: Rana, Vipin, et al.
Publicado: (2021)

Curious relationship between cognitive impairment and diabetic retinopathy
por: Kawamura, Takahiko, et al.
Publicado: (2015)

Diabetic retinopathy classification for supervised machine learning algorithms
por: Nakayama, Luis Filipe, et al.
Publicado: (2022)

Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy
por: Lee, Kyungwon, et al.
Publicado: (2012)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Beta 2 antagonism in acute respiratory failure
por: Sweeney, Rob Mac, et al.
Publicado: (2010)

(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?
por: Wilkinson-Berka, Jennifer L., et al.
Publicado: (2009)

Retinopathy: A sign of cerebral small vessel disease in diabetes?
por: Umemura, Toshitaka, et al.
Publicado: (2017)

Commentary: Rapid assessment of avoidable blindness and diabetic retinopathy in India
por: Misra, Neha, et al.
Publicado: (2020)

Commentary: Predictors of development and progression of diabetic retinopathy: A precis
por: Moharana, Bruttendu, et al.
Publicado: (2021)

Commentary: Shifting our focus to diabetic retinopathy is the need of the hour
por: Kohli, Piyush, et al.
Publicado: (2022)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

New Insights Into the Management of Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M
Publicado: (2013)

Müller Cell–Microglia Cross Talk Drives Neuroinflammation in Diabetic Retinopathy
por: Abcouwer, Steven F.
Publicado: (2017)

Commentary: Targeted screening for effective detection of vision threatening diabetic retinopathy
por: Giridhar, Anantharaman
Publicado: (2021)

Commentary: Obstructive sleep apnea: A silent associate of diabetic retinopathy
por: Ramasamy, Kim, et al.
Publicado: (2021)

Commentary: Recent concepts of pathophysiology and advancements in treatment strategies of diabetic retinopathy
por: Singh, Ankur, et al.
Publicado: (2021)

Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
por: Chang, Chia‐Hsuin, et al.
Publicado: (2013)

CDK4, a new metabolic sensor that antagonizes AMPK
por: Fajas, L., et al.
Publicado: (2018)

Commentary on “Antiseizure activity by opioid receptor antagonism, new evidence”
por: de Witte, Peter
Publicado: (2022)

Commentary on “Community care for diabetic retinopathy and glaucoma in India: A panel discussion”
por: Kumar, Atul, et al.
Publicado: (2018)

Commentary: Role of hyperhomocysteinemia in proliferative diabetic retinopathy: A case–control study
por: Ramasamy, Kim, et al.
Publicado: (2018)

Commentary: Strengthening the health system for providing care for diabetic retinopathy in South Asia
por: Misra, Neha, et al.
Publicado: (2020)

Commentary: Understanding diabetic retinopathy trends in India: Lessons learnt and future implications
por: Agarwal, Divya, et al.
Publicado: (2021)

A Clinical Conundrum: Intensifying Glycemic Control in the Presence of Advanced Diabetic Retinopathy
por: Ipp, Eli, et al.
Publicado: (2021)

Autophagy positively regulates Wnt signaling in mice with diabetic retinopathy
por: Ye, Sihao, et al.
Publicado: (2021)

Center-surround Antagonism Mediated by Proton Signaling at the Cone Photoreceptor Synapse
por: Barnes, Steven
Publicado: (2003)

α(+)Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait
por: Amaratunga, Chanaki, et al.
Publicado: (2014)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

Longitudinal Validation of Hemoglobin A(1c) Criteria for Diabetes Diagnosis: Risk of Retinopathy
por: Sobrin, Lucia
Publicado: (2012)

MicroRNA15a — A Molecule Modulating Multiple Pathologies in Diabetic Retinopathy
por: Chakrabarti, Subrata
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_prfpmh9jno5ohrgvj80b6narb9